Dutasteride in Switzerland for Hair Loss

Dutasteride is studied in hereditary hair loss as another inhibitor of the hormone DHT. In Switzerland the legal situation is different from finasteride, because there is no authorisation for hair loss. This guide explains what that means, what the studies show and which risks are known. It does not replace medical advice and contains no dosing recommendation.

Authorisation in Switzerland and abroad

Swissmedic's list of authorised medicines contains several dutasteride products, including Avodart, generics and combinations with tamsulosin. All are prescription-only in dispensing category B, and all are authorised exclusively for treating benign prostate enlargement (benign prostatic hyperplasia). ^{[1] [2]} No product in Switzerland is authorised for hair loss.

Abroad the picture is partly different. In South Korea, dutasteride has been authorised for hereditary hair loss in men since 2009. ^[4] In Japan, the medicines agency PMDA reviewed and approved a dutasteride product for hair loss in men in 2015. ^[3] There is no such authorisation in the EU or the USA.

For you, this means that any use for hair loss in Switzerland takes place outside the authorisation.

What off-label means in practice

Off-label means that an authorised medicine is used for a purpose that is not covered by its authorisation. This is not prohibited in Switzerland, but it shifts responsibility. The doctor has to know the current state of knowledge, weigh the benefits and risks in your individual case and tell you that the authorisation is missing. The product information gives no guidance for use in hair loss.

A doctor can also prescribe an individually compounded formula, which a pharmacy prepares for a specific person. Such formulas do not need Swissmedic authorisation, but may only be dispensed on a doctor's prescription. ^[17]

Basic health insurance does not pay for dutasteride for hair loss. Off-label use for an indication classed as cosmetic is self-pay. The guide to the cost of hair loss treatment in Switzerland covers the costs of all routes.

How dutasteride works

Like finasteride, dutasteride belongs to the 5-alpha reductase inhibitors. These enzymes convert testosterone into dihydrotestosterone (DHT), which shrinks hair follicles in people with a genetic predisposition. Finasteride mainly inhibits type II of the enzyme. Dutasteride inhibits both type I and type II and therefore lowers DHT more strongly. ^{[5] [16]}

This dual inhibition is the reason dutasteride has been studied for hair loss. It is also why side effects are a key question, because the effect on hormones is more pronounced. Dutasteride also stays in the body for a long time, with a half-life of 3 to 5 weeks according to the product information. This matters in case of side effects or plans to have children and should be discussed with a doctor. ^[2]

The comparison finasteride vs minoxidil explains how those two ingredients differ. You can find more about the ingredient itself on the dutasteride page.

What the studies show

Most studies last 24 weeks and include men aged between 18 and 50. The table summarises the most important randomised studies and meta-analyses.

The data point to a somewhat stronger effect than finasteride. The limitations are the short duration, partly open-label designs and the manufacturer's involvement in several studies. How an individual responds cannot be derived from this.

Side effects and safety

The known side effects are similar to those of finasteride. Sexual dysfunction such as reduced libido or erectile problems is the main concern. A meta-analysis of placebo-controlled studies found a 1.37-fold higher risk for dutasteride, but with few studies this was not statistically significant. ^[11] In a 52-week Japanese long-term study, 17% of participants had side effects attributed to the medicine, and none led to stopping treatment. ^[12]

The Swiss product information for Avodart, based on studies in prostate enlargement, lists impotence, ejaculation disorders, breast enlargement and breast tenderness as common. ^[2] In November 2025 Swissmedic issued information on finasteride and dutasteride. People taking dutasteride should seek medical advice promptly if their mood changes. According to Swissmedic, the evidence for a direct link between dutasteride and suicidal thoughts is insufficient. ^[13]

Long-term data over several years in young men with hair loss are limited. That is an important part of the decision. The guide to finasteride side effects covers the related side effects of finasteride.

Dutasteride on the scalp or as an injection

To limit the effect on the body, dutasteride is also being studied locally, for example as injections into the scalp (mesotherapy) or in topical preparations. A systematic review found much less data for injections than for tablets, with the figures coming from a single study. ^[14] A 2025 network meta-analysis rated mesotherapy with dutasteride as significantly less effective than taking it by mouth. ^[15]

A 2024 review describes some effect for local use, but no standardised protocols. ^[16] There are no large pivotal studies so far for topical dutasteride preparations on the scalp. In Switzerland, such forms are only possible as a compounded formula prescribed by a doctor. ^[17]

Who decides on dutasteride

Whether dutasteride is an option at all, in what form, and whether an authorised ingredient such as finasteride or minoxidil should be considered first, is decided by a doctor after an assessment. Key factors are the diagnosis, your age, previous conditions, other medicines, plans to have children and how you feel about off-label use.

A doctor has to explain the missing authorisation, the evidence and possible side effects to you. Feel free to ask questions, for example about how long treatment lasts, follow-up checks and what happens when you stop. The guide to finasteride prescriptions in Switzerland explains the prescription route for the authorised ingredient finasteride. For context on hair loss in Switzerland, see hair loss in Switzerland in numbers.

At orva, you start with an online consultation, a medical questionnaire. Licensed Swiss physicians review your answers and decide whether treatment is medically appropriate, and which one. If it is, a prescription can be issued. You can find current prices in orva's pricing overview.